Dr. Shriram Arvind Inamdar

Helping Cancer patients with NGO’s
A medical professional with extensive experience in oncology research and clinical trials. Dr. Inamdar's objective is to establish Indigenous Medicine as a part of the treatment of cancer and other chronic illnesses.

Schedule an Appointment


    Dr. Shriram Arvind Inamdar is a Preventive Oncologist specializing in integrated counseling for cancer patients and families. As the Director of Clinical Operations at Xylem Research LLP in Pune, India, he is committed to establishing indigenous medicine, particularly Ayurvedic practices, as part of cancer treatment.

    Dr. Inamdar actively engages in research projects and clinical trials, embracing each challenge as an opportunity for personal and professional growth. His dedication to holistic healthcare exemplifies his commitment to advancing oncology while providing compassionate care to patients.

    Qualifications: ​

    • B.A.M.S. (Bachelor of Ayurvedic medicine and surgery) in Tilak Ayurved Maha Vidyala from Pune University in April 1998 (Medical Registration No: I-35853-A-1)
    • P.G.D.M.L.S. (Post Graduate Diploma in Medico Legal System) Symbiosis center of health care in 2000, Pune.
    • Training is done for one year under the guidance of Vaidya Balendu Prakash  (Padmashree) at Vaidya Chandraprakash Cancer Research Foundation –Dehradun (Uttaranchal) 2001-2002
    • Professional & Advanced Diploma in Clinical Research (PDCR&ACCR) from Catalyst Clinical Services-2004
    • P.G.D.H.A.(PG-diploma in hospital administration. Apollo hospitals -2004)
    • The Foundation Certificate Course in Palliative Medicine from Cipla Palliative & Training Center, Pune -2006
    • Cancer Management-Basics in Cancer Patient Care From Ruby Hall Clinic, Pune -2007
    • MS-Psychology 2 years Diploma –Institute of Behavioral Management Sciences-A.P.in 2012/14.
    • MBA – Hospital Administration & Health Care Management in Distension from DPU. Pune – Feb 2021.

    Clinical Trial Experience:

    Within Oncology, Dr. Inamdar has played pivotal roles in numerous studies, showcasing versatility and proficiency:

    • Breast Cancer: Led 15 Phase III studies and a Phase IV study as a meticulous Study Coordinator.
    • Ovarian Cancer: Managed Phase III and II/III studies with precision, driving effective coordination as a Study Coordinator.
    • Lung Cancer: Contributed significantly to Phase III trials, ensuring smooth study operations as a Study Coordinator.
    • Colo-Rectal, Pancreas, and Gall Bladder Cancers: Provided invaluable support as a Study Coordinator across various Phase II and III trials.
    • G-CSF & G_MCSF: Demonstrated expertise in managing Phase IV trials as a Study Coordinator.
    • Diverse Contributions: Acted as a Sub-Investigator across a spectrum of studies, including GI Cancer, Oral Mucocytosis, Nausea Vomiting, Prostate Cancer, Thyroid Cancer, and Head & Neck cancers.

    In the realm of Gastroenterology, Dr. Inamdar’s contributions have been notable:

    • Ulcerative Colitis: Offered expertise as a Sub-Investigator in Phase III trials.
    • GERD: Played a crucial role as a Sub-Investigator in Phase III trials.
    • Irritable Bowel Syndrome (IBS): Demonstrated proficiency as a Diverticulum in Phase III trials.

    Dr. Inamdar’s involvement in Orthopedics includes significant contributions to Phase III trials focusing on Osteoarthritis and Rheumatoid Arthritis, where he served as a dedicated Sub-Investigator.

    In the domain of Cardiology, Dr. Inamdar contributed as a Sub-Investigator in Phase III trials focusing on LDL Cholesterol, showcasing adeptness and commitment.

    Dr. Inamdar’s expertise extends to Dermatology and Psychiatry:

    • In Dermatology, he participated as a Sub-Investigator in a Phase II trial concentrating on Psoriasis.
    • In Psychiatry, he contributed as a Sub-Investigator in a Phase III trial focusing on Schizophrenia.

    Dr. Inamdar’s roles in Surgery/Medicine encompass a wide array of responsibilities:

    • From addressing Wound Infection and Hemorrhoids as a Sub-Investigator in Phase II trials to handling Deep Vein Thrombosis (DVT) and Type 2 Diabetes Mellitus (DM) as a Diverticulum and Sub-Investigator respectively in Phase II/III trials.
    • He also contributed to Phase II/III trials focusing on Asthma, Phase I/II trials involving COVID (Vaccine & Treatment), and Phase II/III trials on Dendritic Cells Therapy, showcasing his versatility and dedication.

    Dr. Inamdar’s leadership acumen shines through his role as a Start-up CRO for the Ministry of Ayush. He successfully initiated and trained 14 sites in India for COVID treatment studies, emphasizing his commitment to advancing medical research.

    Dr. Shriram Arvind Inamdar’s profound expertise, coupled with his leadership prowess, underscores his invaluable contributions to the advancement of clinical research and medical science.